Cholangiocarcinomas express Fas ligand and disable the Fas receptor

Hepatology

Volumn 30, Issue 6, 1999, Pages 1398-1404

  Que, Florencia G ^a,b   Phan, Vy A ^a   Phan, Van H ^a   Celli, Adrianne ^a   Batts, Kenneth ^a   LaRusso, Nicholas F ^a   Gores, Gregory J ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ADENOCARCINOMA; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CELL DEATH; COMPETITIVE INHIBITION; COMPLEX FORMATION; CYTOTOXIC T LYMPHOCYTE; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 0032697242     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300618     Document Type: Article

References (21)

1. Keane MM, Ettenberg SA, Lowrey GA, Russell EK, Lipkowitz S. Fas expression and function in normal and malignant breast cell lines. Cancer Research 1996;56:4791-4798.
2. Ungenfroren H, Boss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, Kaltfof H. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 1998;58: 1741-1749.
3. Robertson MJ, Manley TJ, Pichert G, Cameron C, Cochran KJ, Levine H, Ritz J. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk Lymph 1995;17:51-65.
4. Tillman DM, Harwood FG, Houghton AAGA. Expression of genes that regulate Fas signaling and Fas-mediated apoptosis in colon carcinoma cells. Cell Death Diff 1998;5:450-457.
5. Suzuki I, Fink PJ. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med 1998;187:123-128.
6. Irmler M, Thomae M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997;388:190-195.
7. Srinivasul SM, Ahmad M, Ottilie S, Bullrich F, Banks S, Want Y, Fernandes-Alnemri T, et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J Biological Chem 1997;272:18542-18545.
8. Chu K, Niu X, Williams LT. A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc Natl Acad Sci 1995;92:11894-11898.
9. Murakami T, Yano H, Maruiwa M, Sugihara S, Kojiro M. Establishment and characterization of human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice. HEPATOLOGY 1987;7:551-556.
10. Tsuda EA. Inhibitory effect of antineoplasm A 10 on breast cancer transplanted to athymic mice and human hepatocellular carcinoma cell lines. Hurume Med J 1990;37:97-104.
11. H Se. Human bile duct carcinoma cell line producing abundant mucin in vitro. Gastroenterology Japnica 22:474-479.
12. Natoli G, Ianni A, Costanzo A, De Petrillo G, Ilari I, Chirillo P, Balsano C, et al. Resistance to Fas mediated apoptosis in human hepatoma cells. Oncogene 1995;11:1061-1067.
13. Pitti M, Marsters SA, Lawrence DA, Roy M, Kischel FC, Dowd P, Huang A, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998;396:699-703.
14. Holtz-Heppelmann CJ, Algeciras A, Badley AD, Paya CV. Transcriptional regulation of the human FasL promoter-enhancer region. J Biological Chem 1998;273:4416-6623.
15. Alpini G, Ulrich CD, Phillips JO, Pham LD, Miller LJ, LaRusso NE Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol 1994;266:G922-G928.
16. Reyher UV, Strater J, Kittstein W, Gschwendt M, Krammer PH, Moller P. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 1998;58:526-534.
17. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, et al. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996;274:1363-1366.
18. Lebel M, Bertrand R, Mesmasson A. Decreased Fas antigen expression in testicular-tumor cell-lines derived from polyomavirus large T-antigen transgenic mice. Oncogene 1996;12:1127-1135.
19. Hu S, Incenzi C, Ni J, Gentz R, Dixit VM. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95-induced apoptosis. J Biological Chem 1997;272:17255-17257.
20. Dirks W, Schone S, Uphoff C, Quentmeier H, Pradella S, Drexler HG. Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines. Br J Haematol 1997;96:584-593.
21. Freiberg RA, Spencer DM, Chaote KA, Duh HJ, Schreiber SL, Crabtree GR, Khavari PA. Fas signals transduction triggers either proliferation or apoptosis in human fibroblasts. J Invest Dermatol 1997;108:215-219.